In breast cancer patients, c-Myc amplification was found more often in patients with BRCA1 deficiency than in patients with normal BRCA1 [47], suggesting that c-Myc amplification could be linked to decreased BRCA1 but the mechanism is poorly understood. This evidence concerns the gene BRCA1 and breast carcinoma.